215 related articles for article (PubMed ID: 24844137)
21. Diagnostic validation of a familial hypercholesterolaemia cohort provides a model for using targeted next generation DNA sequencing in the clinical setting.
Hinchcliffe M; Le H; Fimmel A; Molloy L; Freeman L; Sullivan D; Trent RJ
Pathology; 2014 Jan; 46(1):60-8. PubMed ID: 24300713
[TBL] [Abstract][Full Text] [Related]
22. Performance evaluation of the next-generation sequencing approach for molecular diagnosis of hereditary hearing loss.
Sivakumaran TA; Husami A; Kissell D; Zhang W; Keddache M; Black AP; Tinkle BT; Greinwald JH; Zhang K
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):1007-16. PubMed ID: 23525850
[TBL] [Abstract][Full Text] [Related]
23. Detection of 16S rRNA and KPC Genes from Complex Matrix Utilizing a Molecular Inversion Probe Assay for Next-Generation Sequencing.
Stefan CP; Hall AT; Minogue TD
Sci Rep; 2018 Feb; 8(1):2028. PubMed ID: 29391471
[TBL] [Abstract][Full Text] [Related]
24. Applications.
Josko D
Clin Lab Sci; 2014; 27(3):179-84. PubMed ID: 25219076
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of an integrated clinical workflow for targeted next-generation sequencing of low-quality tumor DNA using a 51-gene enrichment panel.
Choudhary A; Mambo E; Sanford T; Boedigheimer M; Twomey B; Califano J; Hadd A; Oliner KS; Beaudenon S; Latham GJ; Adai AT
BMC Med Genomics; 2014 Nov; 7():62. PubMed ID: 25395014
[TBL] [Abstract][Full Text] [Related]
26. Human papillomavirus genotyping by 454 next generation sequencing technology.
Barzon L; Militello V; Lavezzo E; Franchin E; Peta E; Squarzon L; Trevisan M; Pagni S; Dal Bello F; Toppo S; Palù G
J Clin Virol; 2011 Oct; 52(2):93-7. PubMed ID: 21802982
[TBL] [Abstract][Full Text] [Related]
27. Design of targeted, capture-based, next generation sequencing tests for precision cancer therapy.
Hagemann IS; Cottrell CE; Lockwood CM
Cancer Genet; 2013 Dec; 206(12):420-31. PubMed ID: 24388712
[TBL] [Abstract][Full Text] [Related]
28. Toward Better Oversight of NGS Tests.
Cancer Discov; 2016 Sep; 6(9):OF4. PubMed ID: 27457361
[TBL] [Abstract][Full Text] [Related]
29. Orthogonal NGS for High Throughput Clinical Diagnostics.
Chennagiri N; White EJ; Frieden A; Lopez E; Lieber DS; Nikiforov A; Ross T; Batorsky R; Hansen S; Lip V; Luquette LJ; Mauceli E; Margulies D; Milos PM; Napolitano N; Nizzari MM; Yu T; Thompson JF
Sci Rep; 2016 Apr; 6():24650. PubMed ID: 27090146
[TBL] [Abstract][Full Text] [Related]
30. College of American Pathologists' laboratory standards for next-generation sequencing clinical tests.
Aziz N; Zhao Q; Bry L; Driscoll DK; Funke B; Gibson JS; Grody WW; Hegde MR; Hoeltge GA; Leonard DG; Merker JD; Nagarajan R; Palicki LA; Robetorye RS; Schrijver I; Weck KE; Voelkerding KV
Arch Pathol Lab Med; 2015 Apr; 139(4):481-93. PubMed ID: 25152313
[TBL] [Abstract][Full Text] [Related]
31. HLA typing by next-generation sequencing - getting closer to reality.
Gabriel C; Fürst D; Faé I; Wenda S; Zollikofer C; Mytilineos J; Fischer GF
Tissue Antigens; 2014 Feb; 83(2):65-75. PubMed ID: 24447174
[TBL] [Abstract][Full Text] [Related]
32. Clinical application of amplicon-based next-generation sequencing in cancer.
Chang F; Li MM
Cancer Genet; 2013 Dec; 206(12):413-9. PubMed ID: 24332266
[TBL] [Abstract][Full Text] [Related]
33. Development of a next-generation sequencing method for BRCA mutation screening: a comparison between a high-throughput and a benchtop platform.
Chan M; Ji SM; Yeo ZX; Gan L; Yap E; Yap YS; Ng R; Tan PH; Ho GH; Ang P; Lee AS
J Mol Diagn; 2012 Nov; 14(6):602-12. PubMed ID: 22921312
[TBL] [Abstract][Full Text] [Related]
34. A high-throughput next-generation sequencing assay for the mitochondrial genome.
Dames S; Eilbeck K; Mao R
Methods Mol Biol; 2015; 1264():77-88. PubMed ID: 25631005
[TBL] [Abstract][Full Text] [Related]
35. Next-generation sequencing technologies in diagnostic virology.
Barzon L; Lavezzo E; Costanzi G; Franchin E; Toppo S; Palù G
J Clin Virol; 2013 Oct; 58(2):346-50. PubMed ID: 23523339
[TBL] [Abstract][Full Text] [Related]
36. Next-generation sequencing - feasibility and practicality in haematology.
Kohlmann A; Grossmann V; Nadarajah N; Haferlach T
Br J Haematol; 2013 Mar; 160(6):736-53. PubMed ID: 23294427
[TBL] [Abstract][Full Text] [Related]
37. Understanding the limitations of next generation sequencing informatics, an approach to clinical pipeline validation using artificial data sets.
Daber R; Sukhadia S; Morrissette JJ
Cancer Genet; 2013 Dec; 206(12):441-8. PubMed ID: 24528889
[TBL] [Abstract][Full Text] [Related]
38. The development of next-generation sequencing assays for the mitochondrial genome and 108 nuclear genes associated with mitochondrial disorders.
Dames S; Chou LS; Xiao Y; Wayman T; Stocks J; Singleton M; Eilbeck K; Mao R
J Mol Diagn; 2013 Jul; 15(4):526-34. PubMed ID: 23665194
[TBL] [Abstract][Full Text] [Related]
39. Clinical Validation of a Next-Generation Sequencing Genomic Oncology Panel via Cross-Platform Benchmarking against Established Amplicon Sequencing Assays.
Kadri S; Long BC; Mujacic I; Zhen CJ; Wurst MN; Sharma S; McDonald N; Niu N; Benhamed S; Tuteja JH; Seiwert TY; White KP; McNerney ME; Fitzpatrick C; Wang YL; Furtado LV; Segal JP
J Mol Diagn; 2017 Jan; 19(1):43-56. PubMed ID: 27836695
[TBL] [Abstract][Full Text] [Related]
40. Sequencing as a first-line methodology for cystic fibrosis carrier screening.
Beauchamp KA; Johansen Taber KA; Grauman PV; Spurka L; Lim-Harashima J; Svenson A; Goldberg JD; Muzzey D
Genet Med; 2019 Nov; 21(11):2569-2576. PubMed ID: 31036917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
